Disability in Biological Technology

HHS Secretary Leavitt Announces Members of the National Biodefense Science Board

... of the American Association on Health and disability (AAHD). She has been involved in the disability field for nearly 25 years, working in the areas ... and collaborative opportunities in the disability field. Albert J. Di Rienzo Mr. Di Rienzo ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

... from depression, one of the leading causes of disability in the United States and worldwide," said Elliott ... The key secondary endpoint was the Sheehan disability Scale (SDS), a three-item self-rated instrument ... Depression is one of the leading causes of disability in the U.S.(8) In 2000, the total economic burden ...

Reed Group Ltd. Announces Enterprise License for New Zealand's Accident Compensation Corporation

... -- Reed Group Ltd., publisher of The Medical disability Advisor (MDA) guidelines and a global leader in return- to-work and disability management products and services, announced today ... in the workplace demonstrates the impact of our disability duration guidelines," states Presley Reed, ...

Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy

... Advisor: Workplace Guidelines for disability Duration, Fifth Edition by Presley Reed, MD, MDA ... illnesses of working people. Use of The Medical disability Advisor does not replace the need for consulting ... for all injured and ill workers. The Medical disability Advisor is the world's most widely ...

SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal

... Europe is even more critical with 35% of deaths and almost 1 in 5 of all disability adjusted life years (DALYs) being attributed to the long-term effects of ... as patients are still exposed to increased risk of hypertension induced disability and death(6). The SHARE Program To address the challenges of ...

BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis

... of the disease, including mean change from baseline in the Expanded disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) score. The EDSS is a method of quantifying disability in MS, while the MSFC evaluates additional functional parameters. ...

CorVel Announces MSA Agent Services

... a national provider of leading-edge services and solutions in the field of disability management. CorVel specializes in applying information technology and ... healthcare management in the workers' compensation, group health, auto and disability management insurance markets. The Company provides networks of preferred ...

MUSC's Kilpatrick to Address Congress Regarding PTSD Care

... PTSD in veterans have limited usefulness in determining the level of disability -- Scientific literature supports a type of PTSD, delayed onset, that ... short-term and long-term changes regarding the diagnosis and access to disability benefits for veterans with PTSD. Kilpatrick will be available for ...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

... covered by AutoImmune's license agreement with BioMS, did not meet the primary endpoint of delaying disease progression, as measured by the Expanded disability Status Scale (EDSS), during the two-year Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no ...

First genetically engineered malaria vaccine to enter human trials

... will be trialled in humans from early next year. Malaria kills more than one million people each year and destroys through premature death and disability the equivalent of at least 35 million years of healthy, productive human life every year. Professor Alan Cowman, head of the institute's Infection ...

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

... Jen Hill Baxter (215) 751 7002 (1) Secular data (2) Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis Int. 2006; 17(12):1726-33 (Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO ...

BioMS Medical announces second quarter 2009 results

... defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes. - MAESTRO-02: Eligible patients who have ...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

... future burden of AD. The tool was shown to generate projections for a specified population and generate estimates of disease burden, costs, and/or disability Adjusted Life Years (DALYs), along with the impact of interventions that can reduce risk or slow progression. Projecting the future burden of AD is ...

2009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process

... in elderly persons. Aging is typically associated with a decrease in skeletal muscle mass and muscle function, which contributes decisively to disability in old age and to a loss of quality of life. Resistance training exercise can increase muscle strength, function and mass in older adults. The ...

Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy

... over 17% of the general population suffers from tinnitus and based on a recent report from the Department of Veterans Affairs, tinnitus is now the #1 disability affecting returning troops. While tinnitus can affect anyone, it is more common with increasing age and occurs at higher rates with individuals who ...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

... pain, stiffness and motion restriction in multiple joints. Because RA is a progressive disease, it can cause permanent joint deformity and severe disability if not diagnosed early or if initial treatment is delayed. RA can occur at any age, but is most common in adults 30-50 years old and is two-to-three ...

Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue

... is a wide range of damage that occurs at the cellular level. Our bodies show and feel the results: functionality is lost and age-related frailty, disability and disease take over. Organovo is developing a very promising solution. Their 3-dimensional bio-printer lays down bio-ink that fuses into ...

Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease

... Director at Matrix Genomics. Parkinson's disease is the second most common neurodegenerative disorder in the Western world, and a major cause of disability and distress among older Americans. Family studies have long indicated that Parkinson's is a genetic disorder when certain mutations are inherited. ...

'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher

... for traumatic brain injury patients." Traumatic brain injury (TBI) occurs when an external force injures the brain. TBI is a major cause of disability and death worldwide, but especially in young people. Causes include vehicle accidents, falls, violence, as well as explosive blasts in battle ....

BioMS Medical Announces First quarter 2009 results

... is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes. On April 21, 2009 the DSMB conducted a scheduled ...

Savient Pharmaceuticals Reports First Quarter 2009 Financial Results

... August 1, 2009. First published study to document a significant loss in the quality of life and increased functional disability in patients with treatment failure gout appeared in the Journal of Rheumatology. "We began the year with the notification from ...

Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients

... New Study Published in the Journal of Rheumatology Examines Quality of Life and disability in Treatment Failure Gout Patients EAST BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ...

BioMS Medical's pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board

... the trial is defined as a statistically and clinically significant increase in the time to progression of the disease, as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 70% of all MS patients are HLA-DR2 and/or HLA-DR4 ....

Psylin Neurosciences Commences Development of Compound for Depression

... including some with novel "first-in-class" mechanisms of action such as PSN0041. About Depression Depression is the leading major cause of disability in the United States. According to the National Institute of Mental Health, depression affects approximately 19 million people in the United States. ...

BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board

... for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 70% of all MS patients are HLA-DR2 and/or HLA-DR4 ....

Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis

... Up to 50 percent of survivors have persistent neurological sequelae. Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common in several developing countries in Asia, including India and ...

Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine

... Up to 50 percent of survivors have persistent neurological sequelae. Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common in several developing countries in Asia, including India and ...

Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis

... Up to 50 percent of survivors have persistent neurological sequelae. Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common in several developing countries in Asia, including India and ...

Australian Authorities (TGA) First to Grant Final Product Approval for Intercell's Vaccine to Prevent Japanese Encephalitis

... deaths. Up to 50% of survivors have persistent neurological sequelae. Japanese Encephalitis is the leading cause of viral neurological disease and disability in Asia and the most important viral encephalitis in Asia. The disease is most common in several developing countries in Asia. No treatment is ...

Nonprofit Puts the Power to Cure Neurological Disease in the Hands of the Masses: Texting Technology Brings Awareness & Supports Research

... ability to control their bodies. It may affect a single body area or be generalized throughout multiple muscle groups, and causes varying degrees of disability and pain, from mild to severe. Although treatments exist, dystonia remains a chronic disorder to which there is presently no cure. In North America ...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

... pain, stiffness and motion restriction in multiple joints. Because RA is a progressive disease, it can cause permanent joint deformity and severe disability if not diagnosed early or if initial treatment is delayed. RA can occur at any age, but is most common in adults 30-50 years old and is two-to-three ...

HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City

... to clots that block arteries in the brain. Carotid Artery Disease is a leading cause of these clots. Stroke is the leading cause of serious long-term disability and the third leading cause of death in the United States. Ultrasound scanning of the carotid arteries is the single best predictor of stroke and ...

World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests

... This need not be the case - everyone has access to eye health professionals. Let's make this country the first to prevent unnecessary blindness and disability from glaucoma," Mr Ian Murdoch, Consultant Ophthalmologist, Moorfields Eye Hospital. TV personality Gloria Hunniford, who has lent her support to ...

BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board

... for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 ....

Researchers develop new model for cystic fibrosis

... age-related appearance of disease in the pigs, as well as the organs involved, mimic CF seen in people," Stoltz said. A primary cause of death and disability in patients with CF is lung disease. However, many questions remain about how infection and inflammation leads to lung damage. In the study, the ...

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

... aren't making the connection between their osteoporosis diagnosis and the serious consequences of the disease, namely the risk of fractures and the disability associated with those fractures," said Ethel Siris, M.D., GLOW investigator and Director of the Toni Stabile Osteoporosis Center of the Columbia ...

$1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope

... Disabilities and the Data Coordinating Center at Columbia University. Fragile X syndrome is the most common known cause of inherited intellectual disability and the most common known single gene cause of autism. The effort will advance the core activities of the Fragile X Clinical and Research ...

BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA

... for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 ....

BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis

... the trial is defined as a statistically and clinically significant increase in the time to progression of the disease, as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes. Time to disease progression in patients with other HLA-DR types ...

BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial

... for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 ....